LifeVantage is a science-based network marketing company. It focuses on helping people achieve their health, wellness and financial independence goals. The Company provides products and a financially rewarding direct sales business opportunity to customers and independent distributors seeking a healthy lifestyle and financial freedom. LifeVantage engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim, its scientifically-validated dietary supplement; LifeVantage TrueScience, its line of anti-aging skin care products; Canine Health; Axio, its energy drink mixes, and PhysIQ.
Type
Public
HQ
Sandy, US
Founded
2003
Size (employees)
211 (est)+2%
LifeVantage was founded in 2003 and is headquartered in Sandy, US
Report incorrect company information

LifeVantage Office Locations

LifeVantage has an office in Sandy
Sandy, US (HQ)
300 9785 S Monroe St
Show all (1)
Report incorrect company information

LifeVantage Financials and Metrics

LifeVantage Financials

LifeVantage's revenue was reported to be $206.54 m in FY, 2016 which is a 8.5% increase from the previous period.
USD

Revenue (Q3, 2017)

45 m

Gross profit (Q3, 2017)

36.8 m

Gross profit margin (Q3, 2017), %

81.7%

Net income (Q3, 2017)

61 k

EBIT (Q3, 2017)

223 k

Market capitalization (5-Feb-2018)

50.2 m

Cash (3-Feb-2018)

9.2 m

EV

43 m
LifeVantage's current market capitalization is $50.2 m.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

214 m190.3 m206.5 m

Revenue growth, %

(11%)9%

Cost of goods sold

33.2 m28 m33.9 m

Gross profit

180.8 m162.3 m172.6 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

51.3 m51.5 m55.1 m51.6 m48.2 m45.2 m45.4 m52 m56.2 m54.9 m48.9 m45 m

Cost of goods sold

7.8 m7.9 m8.5 m5.7 m7.5 m7.6 m7 m7.8 m9.7 m8.8 m7.5 m8.2 m

Gross profit

43.5 m43.6 m46.6 m46 m40.8 m37.6 m38.4 m44.2 m46.4 m46.1 m41.4 m36.8 m

Gross profit Margin, %

85%85%85%89%84%83%85%85%83%84%85%82%
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

20.4 m13.9 m7.9 m

Accounts Receivable

1.3 m1 m1.6 m

Inventories

8.8 m9.2 m25.1 m

Current Assets

40 m30.5 m42.4 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

28 m34.5 m35.7 m22.1 m18.6 m15.4 m13.7 m15.8 m8.5 m10.2 m11.7 m9.2 m

Accounts Receivable

923 k873 k2.6 m1.7 m1.1 m1.3 m1.1 m1.7 m2 m1.4 m717 k1.2 m

Inventories

10.6 m9.8 m8.6 m11 m12.1 m10.9 m8.5 m10.6 m17 m23.9 m21.4 m19.1 m

Current Assets

44.9 m52.9 m56.3 m43.8 m38.6 m34.9 m30.9 m36.5 m35.7 m39.6 m36.7 m37.8 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

11.4 m7 m6 m

Depreciation and Amortization

2.1 m2.3 m1.9 m

Cash From Operating Activities

12.1 m13.2 m6 m

Purchases of PP&E

(1.9 m)(1.2 m)(562 k)
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

3.3 m3.3 m2.5 m4.7 m1.5 m573 k1.1 m1.6 m1 m1.2 m283 k61 k

Depreciation and Amortization

499 k498 k530 k

Inventories

11 m12.1 m10.9 m8.5 m10.6 m17 m

Accounts Payable

4.2 m4 m2.7 m2.5 m5.9 m5.9 m7.7 m5 m6.5 m
USDY, 2017

EV/EBIT

193 x

Revenue/Employee

216.4 k

Financial Leverage

3.4 x
Show all financial metrics
Report incorrect company information